Literature DB >> 27408406

Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia.

Asral Wirda Ahmad Asnawi1, Jameela Sathar2, Rashidah Mohamed3, Rohayu Deraman3, Sri Kumaran2, Shahada Sobah Abd Hamid2, Muhd Zanapiah Zakaria2.   

Abstract

Clinical manifestations of sickle cell disease (SCD) arise from the tendency of the sickle haemoglobin to polymerize and deform red blood cells into the characteristic sickle shape. Sickle cell crisis is a devastating complication that may occur in patients with SCD. If not managed properly permanent organ damage and even death may be the final outcome. A case of a 32-year-old Nigerian lady, Gravida 1 Para 0 in her first trimester, with SCD who developed signs and symptoms of delayed haemolytic transfusion reaction after receiving packed red cell transfusion is demonstrated. Multiple red cell alloantibodies were detected in the patient's plasma; anti-Fy a, anti-Jk b and anti-E. The patient miscarriaged and succumbed to complications of hyperhaemolysis with delayed haemolytic transfusion reaction, acute chest syndrome and renal failure. There is an urgent need for mandatory red cell antibody screen and identification especially in high-risk cases. Prevention of alloimmunization by supplying phenotype-specific red cells is also required.

Entities:  

Keywords:  Delayed haemolysis; Hyperhaemolysis; Sickle cell disease; Sickling; Transfusion reaction

Year:  2015        PMID: 27408406      PMCID: PMC4925481          DOI: 10.1007/s12288-014-0495-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  9 in total

1.  Hyperhemolytic transfusion reaction in sickle cell disease.

Authors:  N Win; H Doughty; P Telfer; B J Wild; T C Pearson
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

2.  Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.

Authors:  E P Vichinsky; A Earles; R A Johnson; M S Hoag; A Williams; B Lubin
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

3.  Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.

Authors:  D R Ambruso; J H Githens; R Alcorn; D J Dixon; L J Brown; W M Vaughn; T Hays
Journal:  Transfusion       Date:  1987 Jan-Feb       Impact factor: 3.157

4.  Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.

Authors:  W F Rosse; D Gallagher; T R Kinney; O Castro; H Dosik; J Moohr; W Wang; P S Levy
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

5.  Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.

Authors:  J O Cullis; N Win; J M Dudley; T Kaye
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

6.  A family study of HbS in a Malay family by molecular analysis.

Authors:  Alauddin Hafiza; Hamidah Hussin Noor; Farisah A Razak Noor; Ithnin Azlin; Othman Ainoon
Journal:  Malays J Pathol       Date:  2010-12       Impact factor: 0.656

7.  The sickle cell hemolytic transfusion reaction syndrome.

Authors:  L D Petz; L Calhoun; I A Shulman; C Johnson; R M Herron
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

8.  Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Authors:  Julie-An M Talano; Cheryl A Hillery; Jerome L Gottschall; Diane M Baylerian; J Paul Scott
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

9.  Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

Authors:  John M Higgins; Steven R Sloan
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.